Literature DB >> 28992854

Long-Term and Latent Side Effects of Specific Cancer Types.

Nana Gegechkori1, Lindsay Haines2, Jenny J Lin3.   

Abstract

Although many cancer survivors diagnosed with early-stage disease will outlive their cancer, they may continue to experience long-term and/or latent side effects due to cancer treatment. Many of these side effects are common and contribute to worse quality of life, morbidity, and mortality for cancer survivors. This article summarizes the treatment side effects for several of the most prevalent cancers in the United States.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer survivorship; Cancer treatment; Side effects; Symptom management

Mesh：

Substances：

Year:  2017        PMID： 28992854      PMCID： PMC5777532          DOI： 10.1016/j.mcna.2017.06.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  132 in total

1.  The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom.

Authors:  Nina Schmidt; Louis Jacob; Robert Coleman; Karel Kostev; Peyman Hadji
Journal:  Breast Cancer Res Treat       Date:  2015-12-19       Impact factor: 4.872

2.  2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

Authors:  Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyereislova; Mitch Dowsett; Aron Goldhirsch; Michael Untch; Gabriella Mariani; Jose Baselga; Manfred Kaufmann; David Cameron; Richard Bell; Jonas Bergh; Robert Coleman; Andrew Wardley; Nadia Harbeck; Roberto I Lopez; Peter Mallmann; Karen Gelmon; Nicholas Wilcken; Erik Wist; Pedro Sánchez Rovira; Martine J Piccart-Gebhart
Journal:  Lancet       Date:  2007-01-06       Impact factor: 79.321

3.  Risk of pelvic fractures in older women following pelvic irradiation.

Authors:  Nancy N Baxter; Elizabeth B Habermann; Joel E Tepper; Sara B Durham; Beth A Virnig
Journal:  JAMA       Date:  2005-11-23       Impact factor: 56.272

4.  Anxiety After Diagnosis Predicts Lung Cancer-Specific and Overall Survival in Patients With Stage III Non-Small Cell Lung Cancer: A Population-Based Cohort Study.

Authors:  Andrea Vodermaier; Sarah Lucas; Wolfgang Linden; Robert Olson
Journal:  J Pain Symptom Manage       Date:  2017-01-04       Impact factor: 3.612

5.  Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study.

Authors:  Mai-Britt Bjørklund Ellegaard; Cai Grau; Robert Zachariae; Anders Bonde Jensen
Journal:  Acta Oncol       Date:  2017-01-17       Impact factor: 4.089

Review 6.  Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients.

Authors:  F A Stewart; S Hoving; N S Russell
Journal:  Radiat Res       Date:  2010-08-30       Impact factor: 2.841

7.  Impact of oxaliplatin-induced neuropathy in patients with colorectal cancer: a prospective evaluation at a single institution.

Authors:  R Dault; M P Rousseau; A Beaudoin; M A Frenette; F Lemay; M F Beauchesne
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

8.  Botulinum toxin for radiation-induced facial pain and trismus.

Authors:  Dana M Hartl; Myriam Cohen; Morbize Juliéron; Patrick Marandas; Franéois Janot; Jean Bourhis
Journal:  Otolaryngol Head Neck Surg       Date:  2008-04       Impact factor: 3.497

Review 9.  Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review.

Authors:  Hermine Poghosyan; Lisa Kennedy Sheldon; Suzanne G Leveille; Mary E Cooley
Journal:  Lung Cancer       Date:  2013-04-04       Impact factor: 5.705

10.  High levels of untreated distress and fatigue in cancer patients.

Authors:  L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640
View more
  30 in total

1.  Factors influencing return to work of cancer survivors: a population-based study in Italy.

Authors:  Sara Paltrinieri; Massimo Vicentini; Elisa Mazzini; Elena Ricchi; Stefania Fugazzaro; Pamela Mancuso; Paolo Giorgi Rossi; Stefania Costi
Journal:  Support Care Cancer       Date:  2019-05-25       Impact factor: 3.603

2.  Work Experiences During and After Treatment Among Self-Employed People with Cancer.

Authors:  Steffen Torp; Birgit Brusletto; Tina B Withbro; Bente Nygaard; Linda Sharp
Journal:  J Occup Rehabil       Date:  2020-03

3.  Irish cancer patients and survivors have a positive view of the role of nutritional care in cancer management from diagnosis through survivorship.

Authors:  Laura Keaver
Journal:  Ir J Med Sci       Date:  2021-01-12       Impact factor: 1.568

4.  Associations between baseline demographic, clinical and lifestyle factors, and changes in fatigue, depression, and health-related quality of life in long-term cancer survivors: a cohort study.

Authors:  Shannen R van der Kruk; Kate M Gunn; Ilse Mesters; Brigid M Lynch; Jeff K Vallance; Terry Boyle
Journal:  Support Care Cancer       Date:  2021-01-29       Impact factor: 3.603

Review 5.  Barriers and facilitators to physical activity participation for child, adolescent, and young adult cancer survivors: a systematic review.

Authors:  Tatsiana Adamovich; Rebecca Watson; Sydney Murdoch; Liana Giovino; Sunket Kulkarni; Michael Luchak; Jenna Smith-Turchyn
Journal:  J Cancer Surviv       Date:  2022-06-04       Impact factor: 4.442

Review 6.  [Physical long-term consequences of cancer].

Authors:  Lisa Ernst; Georgia Schilling
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-03-21       Impact factor: 1.513

7.  Effects of structured involvement of the primary care team versus standard care after a cancer diagnosis on patient satisfaction and healthcare use: the GRIP randomised controlled trial.

Authors:  I A A Perfors; C W Helsper; E A Noteboom; E A Visserman; E B L van Dorst; T van Dalen; M A M T Verhagen; A J Witkamp; R Koelemij; A E Flinterman; K A B M Pruissen-Peeters; F M N H Schramel; M T M van Rens; M F Ernst; L M G Moons; E van der Wall; N J de Wit; A M May
Journal:  BMC Prim Care       Date:  2022-06-04

8.  Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.

Authors:  Richard S Finn; Hope S Rugo; Karen A Gelmon; Massimo Cristofanilli; Marco Colleoni; Sherene Loi; Patrick Schnell; Dongrui R Lu; Kathy Puyana Theall; Ave Mori; Eric Gauthier; Eustratios Bananis; Nicholas C Turner; Véronique Diéras
Journal:  Oncologist       Date:  2021-03-10

9.  Association of co-morbidities with financial hardship in survivors of adult cancer.

Authors:  Matthew J Fastiggi; Jin-Ah Sim; I-Chan Huang
Journal:  Support Care Cancer       Date:  2021-05-28       Impact factor: 3.603

10.  Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy.

Authors:  Adriana De La Fuente; Serena Zilio; Jimmy Caroli; Dimitri Van Simaeys; Emilia M C Mazza; Tan A Ince; Vincenzo Bronte; Silvio Bicciato; Donald T Weed; Paolo Serafini
Journal:  Sci Transl Med       Date:  2020-06-17       Impact factor: 19.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.